Compare Linea (LINEA) vs Mira (MIRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Linea vs Mira — how do they compare? Linea trades at Rp37.56 (market cap Rp850,21M, Rp202,54M 24h volume), while Mira trades at Rp698.2 (market cap Rp224,51M, Rp102,44M 24h volume). The key difference: Linea is far larger — about 3.8× Mira's market cap, and Linea's circulating supply is 22,6B / 72B LINEA (32%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold Linea for 28 Days and Mira for 22 Days on average.
| LINEA | MIRA | |
|---|---|---|
Market Cap | Rp850,21M | Rp224,51M |
Volume (24h) | Rp202,54M | Rp102,44M |
Circulating Supply | 22,6B / 72B LINEA (32%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 28 Days | 22 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LINEA is currently trading at Rp38.194 with a bearish technical outlook, showing oversold RSI readings that suggest potential for short-term recovery. The token faces selling pressure with 13 bearish moving average signals against 0 bullish. With only 32% of max supply circulating and a 28-day average hold time, the network shows moderate distribution but limited recent ecosystem growth.
Overall outlook remains cautious with technical indicators signaling bearish momentum despite oversold conditions. Key opportunities include potential bounce from support levels, while major risks involve continued selling pressure and limited fundamental catalysts. Investors should monitor R1 resistance at Rp39 for breakout confirmation.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Linea
Linea is a Layer 2 network built to strengthen Ethereum and its economy. With ETH burn mechanics, native yield, and Ethereum-equivalent zk tech, Linea enhances the value and utility of Ethereum Mainnet. Backed by the largest ecosystem fund and trusted Ethereum builders, Linea offers institutional-grade infrastructure and deep DeFi integration—making it the best chain for ETH capital.
Read more on LINEA →About Mira
Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →
